documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

5 rows where docket_id = "FDA-2005-P-0134" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2005-P-0134-0004 FDA ANDA Suitability for Diphenoxylate Hydrochloride & Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/5 mL - CLOSED FDA-2005-P-0134 Petition Denial from FDA CDER to Lachman Consultant Services, Inc. Other PDN-Petition Denial 2008-12-24T05:00:00Z 2008 12 2008-12-24T05:00:00Z   2024-11-12T18:26:40Z   0 0 09000064807dcaef
FDA-2005-P-0134-0003 FDA ANDA Suitability for Diphenoxylate Hydrochloride & Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/5 mL - CLOSED FDA-2005-P-0134 Citizens Petition from Lachman Consultant Services, Inc. Other CP-Citizen Petition 2008-12-24T05:00:00Z 2008 12 2008-12-24T05:00:00Z   2024-11-12T18:24:31Z   0 0 090000648043fe1e
FDA-2005-P-0134-0005 FDA ANDA Suitability for Diphenoxylate Hydrochloride & Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/5 mL - CLOSED FDA-2005-P-0134 Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations (Electronic Orange Book), April 25, 2005 re Citizens Petition from Lachman Consultant Services, Inc. Supporting & Related Material Background Material 2008-12-24T05:00:00Z 2008 12     2024-11-12T18:30:08Z   0 0 09000064807f8ef6
FDA-2005-P-0134-0001 FDA ANDA Suitability for Diphenoxylate Hydrochloride & Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/5 mL - CLOSED FDA-2005-P-0134 Acknowledgement Letter from FDA DDM to Lachman Consultant Services, Inc. Other Acknowledgement Letter/Receipt 2005-04-27T04:00:00Z 2005 4     2024-11-12T18:21:08Z   0 0 090000648043fe1d
FDA-2005-P-0134-0002 FDA ANDA Suitability for Diphenoxylate Hydrochloride & Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/5 mL - CLOSED FDA-2005-P-0134 Acknowledgement Letter from FDA DDM to Lachman Consultant Services, Inc. Other Acknowledgement Letter/Receipt 2005-04-27T04:00:00Z 2005 4     2024-11-12T18:23:02Z   0 0 090000648043fe20

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);